Standard BioTools Pre-Tax Profit Margin 2010-2023 | LAB
Standard BioTools pre-tax profit margin from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Standard BioTools Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2023-12-31 | $0.11B | $-0.08B | -70.75% |
| 2023-09-30 | $0.11B | $-0.08B | -72.38% |
| 2023-06-30 | $0.11B | $-0.09B | -80.19% |
| 2023-03-31 | $0.10B | $-0.13B | -137.11% |
| 2022-12-31 | $0.10B | $-0.19B | -194.95% |
| 2022-09-30 | $0.11B | $-0.18B | -165.45% |
| 2022-06-30 | $0.11B | $-0.17B | -147.79% |
| 2022-03-31 | $0.13B | $-0.12B | -96.00% |
| 2021-12-31 | $0.13B | $-0.06B | -48.09% |
| 2021-09-30 | $0.14B | $-0.07B | -50.72% |
| 2021-06-30 | $0.15B | $-0.06B | -40.94% |
| 2021-03-31 | $0.14B | $-0.06B | -39.58% |
| 2020-12-31 | $0.14B | $-0.05B | -38.85% |
| 2020-09-30 | $0.13B | $-0.05B | -38.89% |
| 2020-06-30 | $0.11B | $-0.06B | -50.89% |
| 2020-03-31 | $0.11B | $-0.06B | -50.88% |
| 2019-12-31 | $0.12B | $-0.07B | -56.90% |
| 2019-09-30 | $0.12B | $-0.07B | -59.48% |
| 2019-06-30 | $0.12B | $-0.07B | -59.66% |
| 2019-03-31 | $0.12B | $-0.07B | -61.54% |
| 2018-12-31 | $0.11B | $-0.06B | -54.46% |
| 2018-09-30 | $0.11B | $-0.06B | -51.85% |
| 2018-06-30 | $0.10B | $-0.06B | -54.81% |
| 2018-03-31 | $0.10B | $-0.06B | -57.84% |
| 2017-12-31 | $0.10B | $-0.06B | -62.14% |
| 2017-09-30 | $0.10B | $-0.07B | -74.00% |
| 2017-06-30 | $0.10B | $-0.08B | -79.38% |
| 2017-03-31 | $0.10B | $-0.08B | -78.22% |
| 2016-12-31 | $0.10B | $-0.08B | -77.88% |
| 2016-09-30 | $0.11B | $-0.07B | -67.27% |
| 2016-06-30 | $0.12B | $-0.06B | -54.70% |
| 2016-03-31 | $0.12B | $-0.06B | -50.85% |
| 2015-12-31 | $0.12B | $-0.06B | -48.28% |
| 2015-09-30 | $0.12B | $-0.06B | -46.61% |
| 2015-06-30 | $0.12B | $-0.06B | -50.42% |
| 2015-03-31 | $0.12B | $-0.06B | -49.15% |
| 2014-12-31 | $0.12B | $-0.06B | -50.43% |
| 2014-09-30 | $0.11B | $-0.05B | -49.52% |
| 2014-06-30 | $0.09B | $-0.04B | -44.09% |
| 2014-03-31 | $0.08B | $-0.03B | -37.80% |
| 2013-12-31 | $0.07B | $-0.02B | -23.94% |
| 2013-09-30 | $0.07B | $-0.02B | -24.24% |
| 2013-06-30 | $0.06B | $-0.02B | -26.23% |
| 2013-03-31 | $0.06B | $-0.02B | -29.82% |
| 2012-12-31 | $0.05B | $-0.02B | -37.74% |
| 2012-09-30 | $0.05B | $-0.02B | -38.00% |
| 2012-06-30 | $0.05B | $-0.02B | -39.58% |
| 2012-03-31 | $0.05B | $-0.02B | -45.65% |
| 2011-12-31 | $0.04B | $-0.02B | -47.73% |
| 2011-09-30 | $0.04B | $-0.02B | -51.22% |
| 2011-06-30 | $0.04B | $-0.02B | -52.63% |
| 2011-03-31 | $0.04B | $-0.02B | -51.43% |
| 2010-12-31 | $0.03B | $-0.02B | -51.52% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.728B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.275B | 19.92 |
| Inspire Medical Systems (INSP) | United States | $7.566B | 0.00 |
| Axonics (AXNX) | United States | $3.432B | 0.00 |
| 10x Genomics (TXG) | United States | $3.275B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.196B | 0.00 |
| Azenta (AZTA) | United States | $2.979B | 242.82 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.861B | 0.00 |
| Enovis (ENOV) | United States | $2.812B | 20.84 |
| Hims & Hers Health (HIMS) | United States | $2.412B | 0.00 |
| Privia Health (PRVA) | United States | $2.224B | 98.63 |
| Schrodinger (SDGR) | United States | $1.712B | 0.00 |
| Omnicell (OMCL) | United States | $1.384B | 47.83 |
| Phreesia (PHR) | United States | $1.259B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.828B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.383B | 0.00 |
| Pulmonx (LUNG) | United States | $0.378B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.344B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.326B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.202B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.196B | 0.00 |
| American Well (AMWL) | United States | $0.165B | 0.00 |
| Outset Medical (OM) | United States | $0.162B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.125B | 0.00 |
| TruBridge (TBRG) | United States | $0.125B | 5.33 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.108B | 0.00 |
| 111 (YI) | China | $0.096B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Zepp Health (ZEPP) | China | $0.053B | 0.00 |
| Movano (MOVE) | United States | $0.046B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |